Page last updated: 2024-11-05

trifluperidol and Disease Exacerbation

trifluperidol has been researched along with Disease Exacerbation in 1 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Research Excerpts

ExcerptRelevanceReference
"We report on a patient with schizoaffective disorder who was on combination therapy of lithium, carbamazepine, and the neuroleptic trifluperidol."1.30Persistent cerebellar deterioration in a patient with lobar pneumonia under lithium, carbamazepine, and trifluperidol treatment. ( Bischof, F; Fetter, M; Melms, A, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bischof, F1
Melms, A1
Fetter, M1

Other Studies

1 other study available for trifluperidol and Disease Exacerbation

ArticleYear
Persistent cerebellar deterioration in a patient with lobar pneumonia under lithium, carbamazepine, and trifluperidol treatment.
    European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; Antipsychotic Agents; Carbamazepine; Cerebellar Diseases; Disease Progression

1999